Skip to main content
GLUE logo

GLUE · Monte Rosa Therapeutics, Inc.

Track GLUE — free
$15.50 -0.34 (-2.15%) At close · Aug 14
Market Cap
$1.32B
Shares
85.31M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-16 MARKUS WARMUTH 9,500
2026-07-15 Champoux Jennifer 4,351
2026-06-30 FILIP JANKU 5,407
2026-06-29 FILIP JANKU 6,000
2026-06-29 ANTHONY M MANNING 10,000
2026-06-24 FILIP JANKU 30,000
2026-06-23 EDMUND DUNN 16,665
2026-06-23 FILIP JANKU 11,845
2026-06-23 Champoux Jennifer 2,175
2026-06-17 Champoux Jennifer 2,176
2026-06-01 Warmuth Markus 5,466
2026-05-29 SHARON TOWNSON 24,000
2026-05-27 Champoux Jennifer 2,175
2026-05-22 Champoux Jennifer 2,176
2026-05-21 ANTHONY M MANNING 10,000
2026-05-01 Warmuth Markus 5,467
2026-04-16 EDMUND DUNN 18,683
2026-04-14 MARKUS WARMUTH 8,000
2026-04-13 EDMUND DUNN 16,687
2026-04-09 PHILIP NICKSON 5,845
2026-04-08 EDMUND DUNN 26,117
2026-03-04 Dunn Edmund 139
2026-03-02 Edmund Dunn 536
2026-03-02 Warmuth Markus 5,466
2026-02-27 Edmund Dunn 25,164
2026-02-23 FILIP JANKU 9,189
2026-01-07 Warmuth Markus 5,466
2026-01-05 Warmuth Markus 10,135
2024-10-28 Wallace Owen B. 20,000
2024-05-01 Jones Jullian G 105,072
2024-04-10 Jones Jullian G 103,548
2023-08-15 Tamboli Ajim 411,861
Showing 1–32 of 32 filings
Key facts CIK 1826457 CUSIP 61225M102 13F (30d) 188 filings 184 filers Visit website Investor relations